1195 related articles for article (PubMed ID: 873641)
21. Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.
Ohta K; Yamaguchi Y; Shimizu K; Miyahara E; Toge T
Anticancer Res; 2002; 22(5):2597-606. PubMed ID: 12529970
[TBL] [Abstract][Full Text] [Related]
22. Specific lysis of human colon tumor cells by antibodies to CEA and isoantigen A: dependence on rabbit serum or neuraminidase.
Tompkins WA; Seth PB; Yip DM; Palmer JL; Gee SR; Rawls WE
J Immunol; 1976 Nov; 117(5 Pt.2):1943-8. PubMed ID: 792333
[TBL] [Abstract][Full Text] [Related]
23. Immunological reactivity of glycoprotein antigens from human lung cancers.
Harłozińska A; Lisowska E; Richter R; Albert W; Gawlikowski W; Domagała J
Neoplasma; 1980; 27(6):641-52. PubMed ID: 7254422
[TBL] [Abstract][Full Text] [Related]
24. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
Vilien M
Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
[No Abstract] [Full Text] [Related]
25. Four carcinoembryonic antigen subfamily members, CEA, NCA, BGP and CGM2, selectively expressed in the normal human colonic epithelium, are integral components of the fuzzy coat.
Frängsmyr L; Baranov V; Hammarström S
Tumour Biol; 1999; 20(5):277-92. PubMed ID: 10436421
[TBL] [Abstract][Full Text] [Related]
26. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
Surg Forum; 1975; 26():122-4. PubMed ID: 56048
[No Abstract] [Full Text] [Related]
27. Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls.
Troye M; Hansson Y; Paulie S; Perlmann P; Blomgren H; Johansson B
Int J Cancer; 1980 Jan; 25(1):45-51. PubMed ID: 7399744
[TBL] [Abstract][Full Text] [Related]
28. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
[No Abstract] [Full Text] [Related]
29. Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas.
Robbins PF; Eggensperger D; Qi CF; Schlom J
Int J Cancer; 1993 Apr; 53(6):892-7. PubMed ID: 8386136
[TBL] [Abstract][Full Text] [Related]
30. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder.
Alsabti EA; Saffo MH
Urol Int; 1979; 34(5):387-92. PubMed ID: 494440
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
[TBL] [Abstract][Full Text] [Related]
33. A monoclonal antibody against neem leaf glycoprotein recognizes carcinoembryonic antigen (CEA) and restricts CEA expressing tumor growth.
Das A; Barik S; Banerjee S; Bose A; Sarkar K; Biswas J; Baral R; Pal S
J Immunother; 2014 Oct; 37(8):394-406. PubMed ID: 25198527
[TBL] [Abstract][Full Text] [Related]
34. Anti-idiotype antibody induced cellular immunity in mice transgenic for human carcinoembryonic antigen.
Saha A; Chatterjee SK; Foon KA; Bhattacharya-Chatterjee M
Immunology; 2006 Aug; 118(4):483-96. PubMed ID: 16895556
[TBL] [Abstract][Full Text] [Related]
35. Characterization of urothelial carcinoma with respect to the content of carcinoembryonic antigen in exfoliated cells.
Wahren B; Esposti P; Zimmerman R
Cancer; 1977 Oct; 40(4):1511-8. PubMed ID: 332326
[TBL] [Abstract][Full Text] [Related]
36. Immunochemical studies on carcinoembryonic antigen-reactive glycoproteins from carcinomas of the colon and breast separated by concanavalin A affinity chromatography.
Harvey SR; Girotra RN; Nemoto T; Ciani F; Chu TM
Cancer Res; 1976 Sep; 36(9 PT 2):3486-94. PubMed ID: 975108
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen (CEA)-specific T-cell activation in colon carcinoma induced by anti-CD3 x anti-CEA bispecific diabodies and B7 x anti-CEA bispecific fusion proteins.
Holliger P; Manzke O; Span M; Hawkins R; Fleischmann B; Qinghua L; Wolf J; Diehl V; Cochet O; Winter G; Bohlen H
Cancer Res; 1999 Jun; 59(12):2909-16. PubMed ID: 10383154
[TBL] [Abstract][Full Text] [Related]
38. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
Bergmann-Leitner ES; Abrams SI
J Immunol; 2000 May; 164(9):4941-54. PubMed ID: 10779805
[TBL] [Abstract][Full Text] [Related]
39. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
Bubeník J
Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
Troye M; Vilien M; Pape GR; Perlmann P
Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]